• Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes 

      Riquelme, Erick [Univ Mayor, Fac Sci, Ctr Integrat Biol, Santiago, Chile]; Zhang, Yu; Zhang, Liangliang; Montiel, Maria; Zoltan, Michelle; Dong, Wenli; Quesada, Pompeyo; Sahin, Ismet; Chandra, Vidhi; San Lucas, Anthony; Scheet, Paul; Xu, Hanwen; Hanash, Samir M.; Feng, Lei; Burks, Jared K.; Do, Kim-Anh; Peterson, Christine B.; Nejman, Deborah; Tzeng, Ching-Wei D.; Kim, Michael P.; Sears, Cynthia L.; Ajami, Nadim; Petrosino, Joseph; Wood, Laura D.; Maitra, Anirban; Straussman, Ravid; Katz, Matthew; White, James Robert; Jenq, Robert; Wargo, Jennifer; McAllister, Florencia (CELL PRESS, 2019)
      Most patients diagnosed with resected pancreatic adenocarcinoma (PDAC) survive less than 5 years, but a minor subset survives longer. Here, we dissect the role of the tumor microbiota and the immune system in influencing ...


      Modificado por: Sistema de Bibliotecas Universidad Mayor - SIBUM
      DSpace software copyright © 2002-2018  DuraSpace